Literature Study of Molecular Antibacterial Mechanism of Butterfly Pea (Clitoria ternatea L.) Leaves
Abstract
The bacterium is one of the infectious pathogens that cause infectious diseases. A problem currently developing in the treatment of infectious diseases is antimicrobial resistance. Antimicrobial resistance is the inability of an antibiotic to cure infectious diseases so that new antimicrobial compounds are needed that can kill infectious pathogens (by bacteria, fungi, viruses, and multi-cellular parasites). The butterfly pea plant (Clitoria ternatea L.) has been identified as a potential antibacterial plant. This literature study aims to determine the antibacterial activity and identify molecular mechanisms based on the chemical content of telang leaves that have not been done before.
This literature study uses the systematic literature review (SLR) method to determine the activity and antibacterial mechanisms based on the bioactive compounds contained by using PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyzes) as the review protocol. Data search strategy using search engines: science direct, google scholar, and Pubmed. The keyword search uses a combination of words in the problem statement and uses the Boolean "OR" and "AND".
The finding shows that the relevant literature obtained 22 articles that met the criteria consisting of articles on chemical compounds, antibacterial activities and mechanisms. The SLR results showed that telang leaf has potential as an antibacterial and has a molecular mechanism, namely, interfering with the permeability of cell membranes, inhibiting nucleic acid and protein synthesis and inhibiting the formation of biofilms. Chemical compounds that have the potential as antibacterial agents are kaempferol, quercetin, cyclotide, b-sitosterol alkaloids and tannins.
References
[2] D. C. Oliveira, A. Tomasz, and H. De Lencastre, “Secrets of success of a human pathogen: Molecular evolution of pandemic clones of meticillin-resistant Staphylococcus aureus,” Lancet Infect. Dis., vol. 2, no. 3, pp. 180–189, 2002, doi: 10.1016/S1473-3099(02)00227-X.
[3] G. K. T. Nguyen et al., “Discovery and characterization of novel cyclotides originated from chimeric precursors consisting of albumin-1 chain a and cyclotide domains in the Fabaceae family,” J. Biol. Chem., vol. 286, no. 27, pp. 24275–24287, 2011, doi: 10.1074/jbc.M111.229922.
[4] B. Gollen, J. Mehla, and P. Gupta, “Clitoria ternatea Linn: A Herb with Potential Pharmacological Activities: Future Prospects as Therapeutic Herbal Medicine,” J. Pharmacol. Reports, vol. 3, no. 1, pp. 1–8, 2018.
[5] R. Hendra, S. Ahmad, A. Sukari, M. Y. Shukor, and E. Oskoueian, “Flavonoid analyses and antimicrobial activity of various parts of Phaleria macrocarpa (Scheff.) Boerl fruit,” Int. J. Mol. Sci., vol. 12, no. 6, pp. 3422–3431, 2011, doi: 10.3390/ijms12063422.
[6] J. Makasana, B. Z. Dholakiya, N. A. Gajbhiye, and S. Raju, “Extractive determination of bioactive flavonoids from butterfly pea (Clitoria ternatea Linn.),” Res. Chem. Intermed., vol. 43, no. 2, pp. 783–799, 2017, doi: 10.1007/s11164-016-2664-y.
[7] A. Kumar et al., “Extraction, Phytochemical Screening, Separation and Characterisation of Bioactive Compounds From Leaves Extracts of Clitoria Ternatea Linn. (Aparajita),” Int. J. Res. Ayurveda Pharm., vol. 3, no. 5, pp. 70–77, 2016, doi: 10.7897/2277-4343.075198.
[8] N. Maity, N. Nema, B. Sarkar, and P. Mukherjee, “Standardized Clitoria ternatea leaf extract as hyaluronidase, elastase and matrix-metalloproteinase-1 inhibitor,” Indian J. Pharmacol., 2012, doi: 10.4103/0253-7613.100381.
[9] J. Sivaprabha, J. Supriya, S. Sumathi, P. R. Padma, R. Nirmaladevi, and P. Radha, “A study on the levels of nonenzymic antioxidants in the leaves and flowers of Clitoria ternatea.,” Anc. Sci. Life, vol. 27, no. 4, pp. 28–32, 2008.
[10] E. K. Gilding et al., “Gene coevolution and regulation lock cyclic plant defence peptides to their targets,” New Phytol., 2016, doi: 10.1111/nph.13789.
[11] A. G. Poth et al., “Discovery of cyclotides in the Fabaceae plant family provides new insights into the cyclization, evolution, and distribution of circular proteins,” ACS Chem. Biol., vol. 6, no. 4, pp. 345–355, 2011, doi: 10.1021/cb100388j.
[12] L. Kamilla, S. M. Mansor, S. Ramanathan, and S. Sasidharan, “Antimicrobial activity of Clitoria ternatea (L.) extracts,” Pharmacologyonline, 2009.
[13] S. Dhanasekaran, A. Rajesh, T. Mathimani, S. Melvin Samuel, R. Shanmuganathan, and K. Brindhadevi, “Efficacy of crude extracts of Clitoria ternatea for antibacterial activity against gram negative bacterium (Proteus mirabilis),” Biocatal. Agric. Biotechnol., vol. 21, no. September, p. 101328, 2019, doi: 10.1016/j.bcab.2019.101328.
[14] S. R. Rekha, M. Kulandhaivel, and K. V. Hridhya, “Antibacterial efficacy and minimum inhibitory concentrations of medicinal plants against wound pathogens,” Biomed. Pharmacol. J., 2018, doi: 10.13005/bpj/1368.
[15] S. Ponnusamy, W. E. Gnanaraj, J. M. Antonisamy, V. Selvakumar, and J. Nelson, “The effect of leaves extracts of Clitoria ternatea Linn against the fish pathogens,” Asian Pac. J. Trop. Med., 2010, doi: 10.1016/S1995-7645(10)60173-3.
[16] M. Shahid, A. Shahzad, and M. Anis, “Antibacterial potential of the extracts derived from leaves and in vitro raised calli of medicinal plants Pterocarpus marsupium Roxb., Clitoria ternatea L., and Sanseveiria cylindrica Bojer ex Hook,” Orient. Pharm. Exp. Med., vol. 9, no. 2, pp. 174–181, 2009, doi: 10.3742/opem.2009.9.2.174.
[17] M. He, T. Wu, S. Pan, and X. Xu, “Antimicrobial mechanism of flavonoids against Escherichia coli ATCC 25922 by model membrane study,” Appl. Surf. Sci., vol. 305, pp. 515–521, 2014, doi: 10.1016/j.apsusc.2014.03.125.
[18] K. N. T. Nguyen, G. K. T. Nguyen, P. Q. T. Nguyen, K. H. Ang, P. C. Dedon, and J. P. Tam, “Immunostimulating and Gram-negative-specific antibacterial cyclotides from the butterfly pea (Clitoria ternatea),” FEBS J., vol. 283, no. 11, pp. 2067–2090, 2016, doi: 10.1111/febs.13720.
[19] S. S. Efimova, A. A. Zakharova, and O. S. Ostroumova, “Alkaloids Modulate the Functioning of Ion Channels Produced by Antimicrobial Agents via an Influence on the Lipid Host,” Front. Cell Dev. Biol., vol. 8, no. June, pp. 1–16, 2020, doi: 10.3389/fcell.2020.00537.
[20] Y. Xu et al., “Antimicrobial Activity of Punicalagin Against Staphylococcus aureus and Its Effect on Biofilm Formation,” Foodborne Pathog. Dis., vol. 14, no. 5, pp. 282–287, 2017, doi: 10.1089/fpd.2016.2226.
[21] Y. H. Huang, C. C. Huang, C. C. Chen, K. J. Yang, and C. Y. Huang, “Inhibition of Staphylococcus aureus PriA Helicase by Flavonol Kaempferol,” Protein J., vol. 34, no. 3, pp. 169–172, 2015, doi: 10.1007/s10930-015-9609-y.
[22] C. C. Chen and C. Y. Huang, “Inhibition of klebsiella pneumoniae dnab helicase by the flavonol galangin,” Protein J., vol. 30, no. 1, pp. 59–65, 2011, doi: 10.1007/s10930-010-9302-0.
[23] A. González et al., “Identifying potential novel drugs against Helicobacter pylori by targeting the essential response regulator HsrA,” Sci. Rep., vol. 9, no. 1, pp. 1–13, 2019, doi: 10.1038/s41598-019-47746-9.
[24] D. Ming et al., “Kaempferol inhibits the primary attachment phase of biofilm formation in Staphylococcus aureus,” Front. Microbiol., vol. 8, no. NOV, pp. 1–11, 2017, doi: 10.3389/fmicb.2017.02263.
[25] K. B. Oh, M. N. Oh, J. G. Kim, D. S. Shin, and J. Shin, “Inhibition of sortase-mediated Staphylococcus aureus adhesion to fibronectin via fibronectin-binding protein by sortase inhibitors,” Appl. Microbiol. Biotechnol., vol. 70, no. 1, pp. 102–106, 2006, doi: 10.1007/s00253-005-0040-8.
[26] A. M. Potshangbam, R. S. Rathore, and P. Nongdam, “Discovery of sulfone-resistant dihydropteroate synthase (DHPS) as a target enzyme for kaempferol, a natural flavanoid,” Heliyon, vol. 6, no. 2, p. e03378, 2020, doi: 10.1016/j.heliyon.2020.e03378.
